NovaBridge Biosciences (NBP): Total Assets
Older than the company's other figures. The latest Total Assets is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
2.61B CNY
As of 2023-12-31
-25.6%
3-year compound annual growth
+1.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | 2.61B CNY | -35.9% | 2024-04-30, Balance as of period end |
| 2022-12-31 | 4.07B CNY | -27.3% | 2024-04-30, Balance as of period end |
| 2021-12-31 | 5.60B CNY | -11.6% | 2023-05-01, Balance as of period end |
| 2020-12-31 | 6.33B CNY | +264.5% | 2022-04-29, Balance as of period end |
| 2019-12-31 | 1.74B CNY | -26.9% | 2021-04-28, Balance as of period end |
| 2018-12-31 | 2.38B CNY | n/a | 2020-04-29, Balance as of period end |